Page 137 - scheppingen
P. 137

EXPRESSION OF MICRORNAS MIR21, MIR146A, AND MIR155 IN TSC
markers for epilepsy. Scientific reports. 2015;5:9522.
77. Iori V, Iyer A, Aronica E, Vezzani A, editors. microRNA146a-mediated epigenetic control of brain
inflammation: new therapeutic opportunities in epilepsy 30th International Epilepsy Congress;
2013; Montreal, Canada.
78. Ravizza T, Iori V, Iyer AM, Aronica E, Vezzani A. miR146a-Mediated Control Of Brain Inflammation:
A New Therapeutic Opportunity In Epilepsy. In: American Epilepsy Society 2013 Annual Meeting
aC, editor.2013.
79. Lukiw WJ, Surjyadipta B, Dua P, Alexandrov PN. Common micro RNAs (miRNAs) target comple-
ment factor H (CFH) regulation in Alzheimer’s disease (AD) and in age-related macular degener-
ation (AMD). Int J Biochem Mol Biol. 2012;3(1):105-16.
80. Lukiw WJ, Zhao Y, Cui JG. An NF-kappaB-sensitive micro RNA-146a-mediated inflammatory circuit
in Alzheimer disease and in stressed human brain cells. J Biol Chem. 2008 Nov 14;283(46):31315-22.
81. Bartfai T, Sanchez-Alavez M, Andell-Jonsson S, et al. Interleukin-1 system in CNS stress: seizures,
fever, and neurotrauma. Annals of the New York Academy of Sciences. 2007 Oct;1113:173-7.
82. Aronica E, Crino PB. Inflammation in epilepsy: clinical observations. Epilepsia. 2011 May;52 Suppl
3:26-32.
83. Desjardins P, Sauvageau A, Bouthillier A, et al. Induction of astrocytic cyclooxygenase-2 in epileptic
patients with hippocampal sclerosis. Neurochem Int. 2003 Mar;42(4):299-303.
84. Vezzani A, Friedman A, Dingledine RJ. The role of inflammation in epileptogenesis.
Neuropharmacology. 2013 Jun;69:16-24.
85. Tarassishin L, Loudig O, Bauman A, Shafit-Zagardo B, Suh HS, Lee SC. Interferon regulatory factor
3 inhibits astrocyte inflammatory gene expression through suppression of the proinflammatory
miR-155 and miR-155*. Glia. 2011 Dec;59(12):1911-22.
86. Tili E, Michaille JJ, Cimino A, et al. Modulation of miR-155 and miR-125b levels following lipopoly-
saccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin
shock. J Immunol. 2007 Oct 15;179(8):5082-9.
87. O’Connell RM, Chaudhuri AA, Rao DS, Baltimore D. Inositol phosphatase SHIP1 is a primary target
of miR-155. Proc Natl Acad Sci U S A. 2009 Apr 28;106(17):7113-8.
88. Woodbury ME, Freilich RW, Cheng CJ, et al. miR-155 Is Essential for Inflammation-Induced
Hippocampal Neurogenic Dysfunction. The Journal of neuroscience : the official journal of the
Society for Neuroscience. 2015 Jul 1;35(26):9764-81.
89. Chew LJ, Takanohashi A, Bell M. Microglia and inflammation: impact on developmental brain inju-
ries. Mental Retardation & Developmental Disabilities Research Reviews. 2006;12(2):105-12.
90. Cohly HH, Panja A. Immunological findings in autism. International Review of Neurobiology.
2005;71:317-41.
91. Noriega DB, Savelkoul HF. Immune dysregulation in autism spectrum disorder. Eur J Pediatr. 2014
Jan;173(1):33-43.
92. Reus GZ, Fries GR, Stertz L, et al. The role of inflammation and microglial activation in the patho-
physiology of psychiatric disorders. Neuroscience. 2015 Aug 6;300:141-54.
93. Wan G, Xie W, Liu Z, et al. Hypoxia-induced MIR155 is a potent autophagy inducer by targeting
multiple players in the MTOR pathway. Autophagy. 2014 Jan;10(1):70-9.
94. Lee JY, Park AK, Lee ES, et al. miRNA expression analysis in cortical dysplasia: regulation of mTOR
and LIS1 pathway. Epilepsy research. 2014 Mar;108(3):433-41.
95. Wong M, Crino PB. Tuberous sclerosis and epilepsy: role of astrocytes. Glia. 2012 Aug;60(8):1244-50.
96. Ruppe V, Dilsiz P, Reiss CS, et al. Developmental brain abnormalities in tuberous sclerosis com-
plex: A comparative tissue analysis of cortical tubers and perituberal cortex. Epilepsia. 2014
Apr;55(4):539-50.
97. Sosunov AA, Wu X, Weiner HL, et al. Tuberous sclerosis: a primary pathology of astrocytes?
Epilepsia. 2008;49 Suppl 2:53-62.
98. Sosunov AA, McGovern RA, Mikell CB, et al. Epileptogenic but MRI-normal perituberal tissue in
Tuberous Sclerosis Complex contains tuber-specific abnormalities. Acta Neuropathol Commun.
2015;3:17.
99. Curatolo P, Aronica E, Jansen A, et al. Early onset epileptic encephalopathy or genetically deter-
mined encephalopathy with early onset epilepsy? Lessons learned from TSC. Eur J Paediatr Neurol. 2016 Mar;20(2):203-11.
 135
five










































   135   136   137   138   139